Exercise duration as a determinant of vascular function and antioxidant balance in patients with coronary artery disease
Male
Cross-Over Studies
Superoxide Dismutase
Coronary Artery Disease
Walking
Middle Aged
Antioxidants
Elasticity
796
Exercise Therapy
03 medical and health sciences
Superoxide Dismutase-1
0302 clinical medicine
Malondialdehyde
Humans
Vascular Resistance
Exercise
Blood Flow Velocity
Aged
DOI:
10.1136/hrt.2010.209080
Publication Date:
2011-02-26T03:10:04Z
AUTHORS (11)
ABSTRACT
<h3>Background</h3> Exercise improves the clinical outcome of patients with coronary artery disease (CAD); however, ideal exercise duration for each patient remains unclear. <h3>Objective</h3> To investigate effects on arterial elastic properties and antioxidant/pro-oxidant mechanisms in CAD. <h3>Design, setting, patients, interventions</h3> Sixty male CAD were randomised into two groups, underwent 30 min or 60 a crossover design 2 weeks9 wash-out period. In all participants aortic radial blood pressures (BP) (augmentation index (AIx)/pulse wave velocity (PWV)) determined at baseline 24 h after exercise. Plasma malonyldialdehyde (MDA) superoxide dismutase (SOD)1 SOD2 levels also measured. <h3>Results</h3> had no effect BP (p=NS all). Walking 30min improved AIx (from 33.79±0.91% to 31.73±0.86%, p<0.001) PWV 9.26±0.95m/s 9.06± 0.21m/s, p<0.001), while 60min adverse vascular stiffness (for AIx: from 33.37± 0.93% 33.73± 1.05%, p=NS PWV: 9.25±0.19m/s 9.37±0.21m/s, p<0.05 mainly older patients). was associated significant 20% increase MDA (p<0.05). SOD1 levels, however it significantly increased 2.26±0.22ng/mL 2.36±0.18ng/mL, p<0.05) but not (p=NS). <h3>Conclusion</h3> Shorter favourable antioxidant effects, longer blunted these beneficial accompanied by function, patients. Further studies are required explore hypothesis that more individualised approach selection appropriate programme should be considered
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (31)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....